The available data so far are reassuring, with no increase in birth defects seen in early studies, but research is still limited, she says
Tirzepatide Once Weekly for the Treatment of Obesity AMG 133 is a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule
Key Products: Trevogrumab, anti-myostatin antibody designed to preserve lean muscle mass that was tested in combination with semaglutide to offset GLP-1-associated muscle loss
The people who run into real trouble are the ones who take it two or three days early, effectively creating a five-day or four-day cycle instead of seven
If you are in our Medial Weight Loss program, tell us about your symptoms and our medical care team will review with you
Other strategies to manage side effects include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, greasy, or spicy foods that may exacerbate nausea Staying well-hydrated , particularly if experiencing vomiting or diarrhoea Gradually escalating the dose as prescribed, allowing your body time to adjust When to seek medical advice : Contact your GP or diabetes care team promptly if you experience severe or persistent vomiting that prevents adequate fluid intake, signs of dehydration, severe abdominal pain (which could indicate pancreatitis or gallbladder problems), or jaundice
